Need help? Our team of experienced experts is here for you with full support.
AKA-341
Cabergoline
Cat. No.
AKA-341
CAS No.
81409-90-7
MF
C26H37N5O2
MW
451.6
Cabergoline is an ergot derived-dopamine D2-like receptor agonist that has high affinity for D2, D3 and 5-HT2B receptors.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Cabergoline
CAS No.
81409-90-7
MF
C26H37N5O2
MW
451.6
Specification
98%
Research Area
Cabergoline is a dopamine agonist used to lower prolactin levels in the body. It is widely used by many athletes to counteract the elevated prolactin levels caused by drugs such as nandrolone decanoate and trenbolone.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Description
Cabergoline is an ergot derived-dopamine D2-like receptor agonist that has high affinity for D2, D3 and 5-HT2B receptors. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a tightly sealed container under an inert atmosphere (nitrogen or argon), protected from light, at -20°C.
References
[1]. Odaka H, et al. Cabergoline, dopamine D2 receptor agonist, prevents neuronal cell death under oxidative stress via reducing excitotoxicity. PloS One. 2014 Jun 10;9(6):e99271.
[2]. Jefferson F, et al. A dopamine receptor d2-type agonist attenuates the ability of stress to alter sleep in mice. Endocrinology. 2014 Nov;155(11):4411-21.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.